MENY

Gällande vårdprogram

Fastställt av Regionala cancercentrum i samverkan 2016-04-21

29. Referenser

    1. Betänkande av utredningen En nationell cancerstrategi. SOU 2009:11.
    2. Gustafsson G, Heyman M, Kogner P. Childhood cancer incidence and survival in Sweden. 1985–2010. The Swedish Childhood Cancer Registry; 2013.  Svenska barnläkarföreningen, sektionen för onkologi och hematologi. http://www.blf.net/ onko/index.html
    3. Barns och ungas hälsa, vård och omsorg 2013. ISBN: 978-91-7555-042-8.
    4. Berlin M, Hulting C. Framtida konsekvenserav sjukdom och skada under uppväxten. Underlagsrapport. Socialstyrelsen; 2013.
    5. Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, et al. Chronic health conditions in adult survivors of childhood cancer. The New England journal of medicine. 2006;355(15):1572-82.
    6. Geenen MM, Cardous-Ubbink MC, Kremer LC, van den Bos C, van der Pal HJ, Heinen RC, et al. Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. Jama. 2007;297(24):2705-15.
    7. Phillips SM, Padgett LS, Leisenring WM, Stratton KK, Bishop K, Krull KR, et al. Survivors of childhood cancer in the United States: prevalence and burden of morbidity. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2015;24(4):653-63.
    8. Lorenzi MF, Xie L, Rogers PC, Pritchard S, Goddard K, McBride ML. Hospital-related morbidity among childhood cancer survivors in British Columbia, Canada: report of the childhood, adolescent, young adult cancer survivors (CAYACS) program. International journal of cancer Journal international du cancer. 2011;128(7):1624-31.
    9. Kremer LC, Mulder RL, Oeffinger KC, Bhatia S, Landier W, Levitt G, et al. A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Pediatric blood & cancer. 2013;60(4):543-9.
    10. Armenian SH, Hudson MM, Mulder RL, Chen MH, Constine LS, Dwyer M, et al. Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. The Lancet Oncology. 2015;16(3):e123-36.
    11. Mulder RL, Kremer LC, Hudson MM, Bhatia S, Landier W, Levitt G, et al. Recommendations for breast cancer surveillance for female survivors of childhood, adolescent, and young adult cancer given chest radiation: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. The Lancet Oncology. 2013;14(13):e621-9.
    12. Kazak AE, Abrams AN, Banks J, Christofferson J, DiDonato S, Grootenhuis MA, et al. Psychosocial Assessment as a Standard of Care in Pediatric Cancer. Pediatric blood & cancer. 2015;62 Suppl 5:S426-59.
    13. Steele AC, Mullins LL, Mullins AJ, Muriel AC. Psychosocial Interventions and Therapeutic Support as a Standard of Care in Pediatric Oncology. Pediatric blood & cancer. 2015;62 Suppl 5:S585-618.
    14. Zeltzer LK, Recklitis C, Buchbinder D, Zebrack B, Casillas J, Tsao JC, et al. Psychological status in childhood cancer survivors: a report from the Childhood Cancer Survivor Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009;27(14):2396-404.
    15. Braam KI et al. Physical exercise training interventions for children and young adults during and after treatment for childhood cancer” (2013) The Chochrane Library 2013, Issue 4.
    16. Schmitz KH et al. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors” (2010)  Medicine &Science in Sports & Exercise, p 1409-1426.
    17. Fysisk aktivitet. Kunskapsunderlag för Folkhälsopolitisk rapport 2010 Statens folkhälsoinstitut.
    18. Kalm M, Karlsson N, Nilsson MK, Blomgren K. Loss of hippocampal neurogenesis, increased novelty-induced activity, decreased home cage activity, and impaired reversal learning one year after irradiation of the young mouse brain. Experimental neurology. 2013;247:402-9.
    19. Han JW, Kim HS, Hahn SM, Jin SL, Shin YJ, Kim SH, et al. Poor bone health at the end of puberty in childhood cancer survivors. Pediatric blood & cancer. 2015;62(10):1838-43.
    20. Morseth B et al. ”Physical activity and bone: The importance of the various mechanical stimuli for bone mineral density. A review” .  Norsk Epidemiologi 2011;20 (2): 173-178.
    21. Dinas PC, Koutedakis Y, Flouris AD. Effects of exercise and physical activity on depression. Irish journal of medical science. 2011;180(2):319-25.
    22. Slater ME, Steinberger J, Ross JA, Kelly AS, Chow EJ, Koves IH, et al. Physical Activity, Fitness, and Cardiometabolic Risk Factors in Adult Survivors of Childhood Cancer with a History of Hematopoietic Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2015;21(7):1278-83.
    23. Wilson CL, Liu W, Yang JJ, Kang G, Ojha RP, Neale GA, et al. Genetic and clinical factors associated with obesity among adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort. Cancer. 2015.
    24. ”Cancer” (2015) Livsmedelsverket.
    25. ”Public health goals” (2015) World Cancer Research Fund International.
    26. "Livsstil - matvanor" (2015). Cancerfonden.
    27. Socialstyrelsens statistik databas (2015).
    28. Swedish Radiation Safety Authority (2015).
    29. Perkins JL, Liu Y, Mitby PA, Neglia JP, Hammond S, Stovall M, et al. Nonmelanoma skin cancer in survivors of childhood and adolescent cancer: a report from the childhood cancer survivor study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005;23(16):3733-41.
    30. ”The Health Consequences of Smoking_50 Years of progress” (2014) US Department of Health and Human Services.
    31. "Cancer i siffror 2013, populärvetenskapliga fakta om cancer” (2013) Socialstyrelsen, Cancerfonden.
    32. ”Folkhälsorapport 2009” (2009) Socialstyrelsen.
    33. Oancea SC, Gurney JG, Ness KK, Ojha RP, Tyc VL, Klosky JL, et al. Cigarette smoking and pulmonary function in adult survivors of childhood cancer exposed to pulmonary-toxic therapy: results from the St. Jude lifetime cohort study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2014;23(9):1938-43.
    34. "World Cancer Report 2014” (2014) World Health Organization
    35. ”Psykisk ohälsa och alkoholkonsumtion – hur hänger det ihop?” (2008) Statens Folkhälsoinstitut rapport 2008:37.
    36. ”Alcohol Use and Secondary Prevention in Psychiatric Care” (2012) C Nehlin Gordh.
    37. ”Bättre insatser vid missbruk och beroende, slutbetänkade av missbruksutredningen” (2011) SOU 2011:35.
    38. ”2013 National report (data 2012) to the EMCDDA” (2013) Swedish National Institute of Public Health.
    39. Paavonen J, Eggert-Kruse W. Chlamydia trachomatis: impact on human reproduction. Human reproduction update. 1999;5(5):433-47.
    40. Klosky JL, Russell KM, Simmons JL, Foster RH, Peck K, Green DM, et al. Medical and sociodemographic factors associated with human papillomavirus (HPV) vaccination adherence among female survivors of childhood cancer. Pediatric blood & cancer. 2015;62(9):1630-6.
    41. ”Models and care to achieve better outcomes for children and young people living with and beyond cancer” (2011) NHS Improvement.
    42. ”Building the evidence: Developing the winning principles for children and young people, Children and Young People Cancer Survivorship” (2010) NHS Improvement.
    43. Poplack DG, Fordis M, Landier W, Bhatia S, Hudson MM, Horowitz ME. Childhood cancer survivor care: development of the Passport for Care. Nature reviews Clinical oncology. 2014;11(12):740-50.
    44. WHO Cancer, Fact sheet No 297(2015) World Health Organization.
    45. Lown EA, Phillips F, Schwartz LA, Rosenberg AR, Jones B. Psychosocial Follow-Up in Survivorship as a Standard of Care in Pediatric Oncology. Pediatric blood & cancer. 2015;62 Suppl 5:S531-601.
    46. Sundberg KK, Doukkali E, Lampic C, Eriksson LE, Arvidson J, Wettergren L. Long-term survivors of childhood cancer report quality of life and health status in parity with a comparison group. Pediatric blood & cancer. 2010;55(2):337-43.
    47. ”Chronic Health Conditions and Premature Mortality in Long-term Survivors of Cancer Diagnosed Between the Age of 15 and 20 years: A Report from the Childhood Cancer Survivors Study” (2014), E Suh mfl, abstract 7th Biennial Cancer Survivorship Research
    48. ”Cancerrehabilitering, Nationellt vårdprogram – ett kunskapsunderlag” från 2014, Landstingens och regionernas nationella samverkansgrupp inom cancervården.
    49. Lehtinen SS, Huuskonen UE, Harila-Saari AH, Tolonen U, Vainionpaa LK, Lanning BM. Motor nervous system impairment persists in long-term survivors of childhood acute lymphoblastic leukemia. Cancer. 2002;94(9):2466-73.
    50. Trobaugh-Lotrario AD, Smith AA, Odom LF. Vincristine neurotoxicity in the presence of hereditary neuropathy. Medical and pediatric oncology. 2003;40(1):39-43.
    51. Chauvenet AR, Shashi V, Selsky C, Morgan E, Kurtzberg J, Bell B, et al. Vincristine-induced neuropathy as the initial presentation of charcot-marie-tooth disease in acute lymphoblastic leukemia: a Pediatric Oncology Group study. Journal of pediatric hematology/oncology. 2003;25(4):316-20.
    52. Ness KK, Jones KE, Smith WA, Spunt SL, Wilson CL, Armstrong GT, et al. Chemotherapy-related neuropathic symptoms and functional impairment in adult survivors of extracranial solid tumors of childhood: results from the St. Jude Lifetime Cohort Study. Archives of physical medicine and rehabilitation. 2013;94(8):1451-7.
    53. Burman C et al Fitting of normal tissue tolerance data to an analytic function.Int. J Radiation Oncology Biol. Phys1991,  Vol. 21, pp. 123-135.
    54. Enami B et al Tolerance of normal tissue to therapeutic irradiation . Inr J. Radiation Oncology tliol. Phys. 1991, Vol. 21, pp. 109-122.
    55. Packer RJ, Gurney JG, Punyko JA, Donaldson SS, Inskip PD, Stovall M, et al. Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: childhood cancer survivor study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003;21(17):3255-61.
    56. Gan HW, Bulwer C, Spoudeas H. Pituitary and Hypothalamic Tumor Syndromes in Childhood. [Updated 2014 Jun 15]. In: De Groot LJ, Beck-Peccoz P, Chrousos G, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
    57. Mulhern RK, Merchant TE, Gajjar A, Reddick WE, Kun LE. Late neurocognitive sequelae in survivors of brain tumours in childhood. The Lancet Oncology. 2004;5(7):399-408.
    58. Grill J, Renaux VK, Bulteau C, Viguier D, Levy-Piebois C, Sainte-Rose C, et al. Long-term intellectual outcome in children with posterior fossa tumors according to radiation doses and volumes. International journal of radiation oncology, biology, physics. 1999;45(1):137-45.
    59. Fouladi M, Gilger E, Kocak M, Wallace D, Buchanan G, Reeves C, et al. Intellectual and functional outcome of children 3 years old or younger who have CNS malignancies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005;23(28):7152-60.
    60. Goldsby RE, Liu Q, Nathan PC, Bowers DC, Yeaton-Massey A, Raber SH, et al. Late-occurring neurologic sequelae in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2010;28(2):324-31.
    61. Cheung YT, Krull KR. Neurocognitive outcomes in long-term survivors of childhood acute lymphoblastic leukemia treated on contemporary treatment protocols: A systematic review. Neuroscience and biobehavioral reviews. 2015;53:108-20.
    62. Peterson CC, Johnson CE, Ramirez LY, Huestis S, Pai AL, Demaree HA, et al. A meta-analysis of the neuropsychological sequelae of chemotherapy-only treatment for pediatric acute lymphoblastic leukemia. Pediatric blood & cancer. 2008;51(1):99-104.
    63. Waber DP, McCabe M, Sebree M, Forbes PW, Adams H, Alyman C, et al. Neuropsychological outcomes of a randomized trial of prednisone versus dexamethasone in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute All Consortium Protocol 00-01. Pediatric blood & cancer. 2013;60(11):1785-91.
    64. Hjern A, Lindblad F, Boman KK. Disability in adult survivors of childhood cancer: a Swedish national cohort study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007;25(33):5262-6.
    65. Macartney G, VanDenKerkhof E, Harrison MB, Stacey D. Symptom experience and quality of life in pediatric brain tumor survivors: a cross-sectional study. Journal of pain and symptom management. 2014;48(5):957-67.
    66. Lannering B, Marky I, Lundberg A, Olsson E. Long-term sequelae after pediatric brain tumors: their effect on disability and quality of life. Medical and pediatric oncology. 1990;18(4):304-10.
    67. Boman KK, Lindblad F, Hjern A. Long-term outcomes of childhood cancer survivors in Sweden: a population-based study of education, employment, and income. Cancer. 2010;116(5):1385-91.
    68. Hornquist L, Rickardsson J, Lannering B, Gustafsson G, Boman KK. Altered self-perception in adult survivors treated for a CNS tumor in childhood or adolescence: population-based outcomes compared with the general population. Neuro-oncology. 2015;17(5):733-40.
    69. Anderson V, Catroppa C, Morse S, Haritou F, Rosenfeld JV. Intellectual outcome from preschool traumatic brain injury: a 5-year prospective, longitudinal study. Pediatrics. 2009;124(6):e1064-71.
    70. Armstrong TS, Cron SG, Bolanos EV, Gilbert MR, Kang DH. Risk factors for fatigue severity in primary brain tumor patients. Cancer. 2010;116(11):2707-15.
    71. Tonks J, Slater A, Frampton I, Wall SE, Yates P, Williams WH. The development of emotion and empathy skills after childhood brain injury. Developmental medicine and child neurology. 2009;51(1):8-16.
    72. Prigatano GP, Gupta S. Friends after traumatic brain injury in children. The Journal of head trauma rehabilitation. 2006;21(6):505-13.
    73. Shah SS, Dellarole A, Peterson EC, Bregy A, Komotar R, Harvey PD, et al. Long-term psychiatric outcomes in pediatric brain tumor survivors. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery. 2015;31(5):653-63.
    74. Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacological reviews. 2004;56(2):185-229.
    75. van Dalen EC, van der Pal HJ, Kok WE, Caron HN, Kremer LC. Clinical heart failure in a cohort of children treated with anthracyclines: a long-term follow-up study. European journal of cancer. 2006;42(18):3191-8.
    76. Mertens AC, Yasui Y, Neglia JP, Potter JD, Nesbit ME, Jr., Ruccione K, et al. Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2001;19(13):3163-72.
    77. Levitt G, Anazodo A, Burch M, Bunch K. Cardiac or cardiopulmonary transplantation in childhood cancer survivors: an increasing need? European journal of cancer. 2009;45(17):3027-34.
    78. Kremer LC, van Dalen EC, Offringa M, Voute PA. Frequency and risk factors of anthracycline-induced clinical heart failure in children: a systematic review. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2002;13(4):503-12.
    79. Kremer LC, van der Pal HJ, Offringa M, van Dalen EC, Voute PA. Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2002;13(6):819-29.
    80. van Dalen EC, van der Pal HJ, Caron HN, Kremer LC. Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy. The Cochrane database of systematic reviews. 2009(4):CD005008.
    81. van Dalen EC, Michiels EM, Caron HN, Kremer LC. Different anthracycline derivates for reducing cardiotoxicity in cancer patients. The Cochrane database of systematic reviews. 2010(5):CD005006.
    82. van Dalen EC, Caron HN, Dickinson HO, Kremer LC. Cardioprotective interventions for cancer patients receiving anthracyclines. The Cochrane database of systematic reviews. 2011(6):CD003917.
    83. Bryant J, Picot J, Levitt G, Sullivan I, Baxter L, Clegg A. Cardioprotection against the toxic effects of anthracyclines given to children with cancer: a systematic review. Health technology assessment. 2007;11(27):iii, ix-x, 1-84.
    84. van Dalen EC, Raphael MF, Caron HN, Kremer LC. Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer. The Cochrane database of systematic reviews. 2011(1):CD006647.
    85. Fulbright JM. Review of cardiotoxicity in pediatric cancer patients: during and after therapy. Cardiology research and practice. 2011;2011:942090.
    86. Wittig A, Engenhart-Cabillic R. Cardiac side effects of conventional and particle radiotherapy in cancer patients. Herz. 2011;36(4):311-24.
    87. Lipshultz SE, Adams MJ, Colan SD, Constine LS, Herman EH, Hsu DT, et al. Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions: a scientific statement from the American Heart Association. Circulation. 2013;128(17):1927-95.
    88. De Bruin ML, Sparidans J, van't Veer MB, Noordijk EM, Louwman MW, Zijlstra JM, et al. Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009;27(26):4239-46.
    89. Bowers DC, McNeil DE, Liu Y, Yasui Y, Stovall M, Gurney JG, et al. Stroke as a late treatment effect of Hodgkin's Disease: a report from the Childhood Cancer Survivor Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005;23(27):6508-15.
    90. Hull MC, Morris CG, Pepine CJ, Mendenhall NP. Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of hodgkin lymphoma treated with radiation therapy. Jama. 2003;290(21):2831-7.
    91. Shankar SM, Marina N, Hudson MM, Hodgson DC, Adams MJ, Landier W, et al. Monitoring for cardiovascular disease in survivors of childhood cancer: report from the Cardiovascular Disease Task Force of the Children's Oncology Group. Pediatrics. 2008;121(2):e387-96.
    92. Scott AS, Parr LA, Johnstone PA. Risk of cerebrovascular events after neck and supraclavicular radiotherapy: a systematic review. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2009;90(2):163-5.
    93. Travis LB, Ng AK, Allan JM, Pui CH, Kennedy AR, Xu XG, et al. Second malignant neoplasms and cardiovascular disease following radiotherapy. Journal of the National Cancer Institute. 2012;104(5):357-70.
    94. Morris B, Partap S, Yeom K, Gibbs IC, Fisher PG, King AA. Cerebrovascular disease in childhood cancer survivors: A Children's Oncology Group Report. Neurology. 2009;73(22):1906-13.
    95. Narins CR, Illig KA. Patient selection for carotid stenting versus endarterectomy: a systematic review. Journal of vascular surgery. 2006;44(3):661-72.
    96. Meyer AK, Young NM. Auditory late effects of chemotherapy. Cancer treatment and research. 2009;150:195-213.
    97. Jereczek-Fossa BA, Zarowski A, Milani F, Orecchia R. Radiotherapy-induced ear toxicity. Cancer treatment reviews. 2003;29(5):417-30.
    98. Bhandare N, Jackson A, Eisbruch A, Pan CC, Flickinger JC, Antonelli P, et al. Radiation therapy and hearing loss. International journal of radiation oncology, biology, physics. 2010;76(3 Suppl):S50-7.
    99. Hua C, Bass JK, Khan R, Kun LE, Merchant TE. Hearing loss after radiotherapy for pediatric brain tumors: effect of cochlear dose. International journal of radiation oncology, biology, physics. 2008;72(3):892-9.
    100. Einarsson EJ, Petersen H, Wiebe T, Fransson PA, Grenner J, Magnusson M, et al. Long term hearing degeneration after platinum-based chemotherapy in childhood. International journal of audiology. 2010;49(10):765-71.
    101. Einarsson EJ, Petersen H, Wiebe T, Fransson PA, Magnusson M, Moell C. Severe difficulties with word recognition in noise after platinum chemotherapy in childhood, and improvements with open-fitting hearing-aids. International journal of audiology. 2011;50(10):642-51.
    102. Postural control in young adults after chemotherapy in childhood. Einarsson EJ, et al.: Thesis 2013, Lunds Universitet.
    103. Oculomotor deficits and self-reported symptoms in young adults after chemotherapy in childhood. Einarsson EJ, et al.: Thesis 2013, Lunds Universitet.
    104. De Bruyne R, Portmann B, Samyn M, Bansal S, Knisely A, Mieli-Vergani G, et al. Chronic liver disease related to 6-thioguanine in children with acute lymphoblastic leukaemia. Journal of hepatology. 2006;44(2):407-10.
    105. Raja RA, Schmiegelow K, Frandsen TL. Asparaginase-associated pancreatitis in children. British journal of haematology. 2012;159(1):18-27.
    106. Jirtle RL et al. Radiation sensitivity of the liver. Adv Radiat Biol. 1990;14:269-311.
    107. Hudson MM, Ness KK, Gurney JG, Mulrooney DA, Chemaitilly W, Krull KR, et al. Clinical ascertainment of health outcomes among adults treated for childhood cancer. Jama. 2013;309(22):2371-81.
    108. Mulder RL, Kremer LC, Koot BG, Benninga MA, Knijnenburg SL, van der Pal HJ, et al. Surveillance of hepatic late adverse effects in a large cohort of long-term survivors of childhood cancer: prevalence and risk factors. European journal of cancer. 2013;49(1):185-93.
    109. Castellino S, Muir A, Shah A, Shope S, McMullen K, Ruble K, et al. Hepato-biliary late effects in survivors of childhood and adolescent cancer: a report from the Children's Oncology Group. Pediatric blood & cancer. 2010;54(5):663-9.
    110. Skinner R. Nephrotoxicity--what do we know and what don't we know? Journal of pediatric hematology/oncology. 2011;33(2):128-34.
    111. Skinner R, Parry A, Price L, Cole M, Craft AW, Pearson AD. Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: relevance of age and dose as risk factors. European journal of cancer. 2009;45(18):3213-9.
    112. Riachy E, Krauel L, Rich BS, McEvoy MP, Honeyman JN, Boulad F, et al. Risk factors and predictors of severity score and complications of pediatric hemorrhagic cystitis. The Journal of urology. 2014;191(1):186-92.
    113. Diller L, Chow EJ, Gurney JG, Hudson MM, Kadin-Lottick NS, Kawashima TI, et al. Chronic disease in the Childhood Cancer Survivor Study cohort: a review of published findings. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009;27(14):2339-55.
    114. Gawade PL, Hudson MM, Kaste SC, Neglia JP, Constine LS, Robison LL, et al. A systematic review of dental late effects in survivors of childhood cancer. Pediatric blood & cancer. 2014;61(3):407-16.
    115. Avsar A, Elli M, Darka O, Pinarli G. Long-term effects of chemotherapy on caries formation, dental development, and salivary factors in childhood cancer survivors. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics. 2007;104(6):781-9.
    116. Nasman M, Forsberg CM, Dahllof G. Long-term dental development in children after treatment for malignant disease. European journal of orthodontics. 1997;19(2):151-9.
    117. Kosuda S, Satoh M, Yamamoto F, Uematsu M, Kusano S. Assessment of salivary gland dysfunction following chemoradiotherapy using quantitative salivary gland scintigraphy. International journal of radiation oncology, biology, physics. 1999;45(2):379-84.
    118. Garming Legert K, Remberger M, Ringden O, Heimdahl A, Dahllof G. Salivary secretion in children after fractionated or single-dose TBI. Bone marrow transplantation. 2012;47(3):404-10.
    119. Vissink A, Jansma J, Spijkervet FK, Burlage FR, Coppes RP. Oral sequelae of head and neck radiotherapy. Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists. 2003;14(3):199-212.
    120. Oral and dental late effects in survivors of childhood cancer: a Children’s Oncology Group report Karen E. Effinger & Cesar A. Migliorati & Melissa M. Hudson & Kevin P. McMullen & Sue C. Kaste & Kathy Ruble & Gregory M. T. Guilcher & Ami J. Shah & Sharon M. Castellino. Support Care Cancer (2014) 22:2009–2019 DOI 10.1007/s00520-014-2260-x.
    121. Goldstein M, Maxymiw WG, Cummings BJ, Wood RE. The effects of antitumor irradiation on mandibular opening and mobility: a prospective study of 58 patients. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics. 1999;88(3):365-73.
    122. Socie G, Salooja N, Cohen A, Rovelli A, Carreras E, Locasciulli A, et al. Nonmalignant late effects after allogeneic stem cell transplantation. Blood. 2003;101(9):3373-85.
    123. Ringdén O, Deeg HJ. Clinical spectrum of graft-versus-hoost disease. In: Ferrara JLM, Deeg HJ, Burakoff S, editors. Graft vs Host Disease. Second Edition. New York; Marcel Dekker, inc., pp 525-559, 1996.
    124. Ringden O, Brazauskas R, Wang Z, Ahmed I, Atsuta Y, Buchbinder D, et al. Second solid cancers after allogeneic hematopoietic cell transplantation using reduced-intensity conditioning. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2014;20(11):1777-84.
    125. Nyheter i tandvårdsstödet.
    126. Pediatric dentistry : a clinical approach Koch G, Poulsen S. Copenhagen: Munksgaard, cop. 2001. 482 p.
    127. Vesterbacka M, Ringden O, Remberger M, Huggare J, Dahllof G. Disturbances in dental development and craniofacial growth in children treated with hematopoietic stem cell transplantation. Orthodontics & craniofacial research. 2012;15(1):21-9.
    128. Mandel ID. The role of saliva in maintaining oral homeostasis. Journal of the American Dental Association. 1989;119(2):298-304.
    129. Pollock JJ, Denepitiya L, MacKay BJ, Iacono VJ. Fungistatic and fungicidal activity of human parotid salivary histidine-rich polypeptides on Candida albicans. Infection and immunity. 1984;44(3):702-7.
    130. Ferguson DB. The physiology and biology of saliva. In: deBurgh Norman JE, McGurk M (Eds.) Color atlas and text of the salivary gland diseases, disorders and surgery. Mosby-Wolfe 1995. Pp 40-48.
    131. Screebny LM. Xerostomia: diagnosis, management and clinical complications. In: Edgar WM, O´Mullane DM (EDS.) Saliva and oral health 2nd ed. British Dental Journal, London 1996. Pp 43-66.
    132. Purdell-Lewis DJ, Stalman MS, Leeuw JA, Humphrey GB, Kalsbeek H. Long term results of chemotherapy on the developing dentition: caries risk and developmental aspects. Community dentistry and oral epidemiology. 1988;16(2):68-71.
    133. Wogelius P, Dahllof G, Gorst-Rasmussen A, Sorensen HT, Rosthoj S, Poulsen S. A population-based observational study of dental caries among survivors of childhood cancer. Pediatric blood & cancer. 2008;50(6):1221-6.
    134. Maguire A, Craft AW, Evans RG, Amineddine H, Kernahan J, Macleod RI, et al. The long-term effects of treatment on the dental condition of children surviving malignant disease. Cancer. 1987;60(10):2570-5.
    135. Nunn JH, Welbury RR, Gordon PH, Kernahan J, Craft AW. Dental caries and dental anomalies in children treated by chemotherapy for malignant disease: a study in the north of England. International journal of paediatric dentistry / the British Paedodontic Society [and] the International Association of Dentistry for Children. 1991;1(3):131-5.
    136. Singh AD, Pelayes DE, Seregard S, Macklis R (eds): Ophthalmic Radiation Therapy. Techniques and Applications. Dev Ophthalmol. Basel, Karger, 2013, vol 52.
    137. Jeganathan VS, Wirth A, MacManus MP. Ocular risks from orbital and periorbital radiation therapy: a critical review. International journal of radiation oncology, biology, physics. 2011;79(3):650-9.
    138. Wong JR, Morton LM, Tucker MA, Abramson DH, Seddon JM, Sampson JN, et al. Risk of subsequent malignant neoplasms in long-term hereditary retinoblastoma survivors after chemotherapy and radiotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014;32(29):3284-90.
    139. Thirman MJ, Larson RA. Therapy-related myeloid leukemia. Hematology/oncology clinics of North America. 1996;10(2):293-320.
    140. Pedersen-Bjergaard J, Philip P. Balanced translocations involving chromosome bands 11q23 and 21q22 are highly characteristic of myelodysplasia and leukemia following therapy with cytostatic agents targeting at DNA-topoisomerase II. Blood. 1991;78(4):1147-8.
    141. Uhnoo I, Lepp T. [Life-threatening infection in splenectomised patients is preventable. But this requires better vaccination routines, education and antibiotic prophylaxis]. Lakartidningen. 2012;109(32-33):1406-10.
    142. O'Connor D, Bate J, Wade R, Clack R, Dhir S, Hough R, et al. Infection-related mortality in children with acute lymphoblastic leukemia: an analysis of infectious deaths on UKALL2003. Blood. 2014;124(7):1056-61.
    143. Molgaard-Hansen L, Mottonen M, Glosli H, Jonmundsson GK, Abrahamsson J, Hasle H, et al. Early and treatment-related deaths in childhood acute myeloid leukaemia in the Nordic countries: 1984-2003. British journal of haematology. 2010;151(5):447-59.
    144. Wiegering V, Frank J, Freudenberg S, Morbach H, Schlegel PG, Eyrich M, et al. Impaired B-cell reconstitution in children after chemotherapy for standard or medium risk acute precursor B-lymphoblastic leukemia. Leukemia & lymphoma. 2014;55(4):870-5.
    145. van Tilburg CM, van Gent R, Bierings MB, Otto SA, Sanders EA, Nibbelke EE, et al. Immune reconstitution in children following chemotherapy for haematological malignancies: a long-term follow-up. British journal of haematology. 2011;152(2):201-10.
    146. Perkins JL, Chen Y, Harris A, Diller L, Stovall M, Armstrong GT, et al. Infections among long-term survivors of childhood and adolescent cancer: a report from the Childhood Cancer Survivor Study. Cancer. 2014;120(16):2514-21.
    147. Price V, Barnes C, Canning P, Blanchette V, Greenberg M. Immune thrombocytopenia following successful treatment of cancer in children. Pediatric blood & cancer. 2006;46(3):372-6.
    148. Patel SR, Ortin M, Cohen BJ, Borrow R, Irving D, Sheldon J, et al. Revaccination of children after completion of standard chemotherapy for acute leukemia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2007;44(5):635-42.
    149. Brodtman DH, Rosenthal DW, Redner A, Lanzkowsky P, Bonagura VR. Immunodeficiency in children with acute lymphoblastic leukemia after completion of modern aggressive chemotherapeutic regimens. The Journal of pediatrics. 2005;146(5):654-61.
    150. Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2014;58(3):309-18.
    151. Klosky JL, Gamble HL, Spunt SL, Randolph ME, Green DM, Hudson MM. Human papillomavirus vaccination in survivors of childhood cancer. Cancer. 2009;115(24):5627-36.
    152. Berger C, Trombert-Paviot B, Casagranda L, Mialou V, Frappaz D, Plantaz D, et al. Second malignant neoplasms following childhood cancer: a study of a recent cohort (1987-2004) from the childhood cancer registry of the Rhone-Alpes region (ARCERRA) in France. Pediatric hematology and oncology. 2011;28(5):364-79.
    153. Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C, et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Bone marrow transplantation. 2012;47(3):337-41.
    154. Nottage K, Lanctot J, Li Z, Neglia JP, Bhatia S, Hammond S, et al. Long-term risk for subsequent leukemia after treatment for childhood cancer: a report from the Childhood Cancer Survivor Study. Blood. 2011;117(23):6315-8.
    155. Shao L, Wang Y, Chang J, Luo Y, Meng A, Zhou D. Hematopoietic stem cell senescence and cancer therapy-induced long-term bone marrow injury. Translational cancer research. 2013;2(5):397-411.
    156. Cersosimo RJ, Matthews SJ, Hong WK. Bleomycin pneumonitis potentiated by oxygen administration. Drug intelligence & clinical pharmacy. 1985;19(12):921-3.
    157. van Hulst RA, Rietbroek RC, Gaastra MT, Schlosser NJ. To dive or not to dive with bleomycin: a practical algorithm. Aviation, space, and environmental medicine. 2011;82(8):814-8.
    158. Huang TT, Hudson MM, Stokes DC, Krasin MJ, Spunt SL, Ness KK. Pulmonary outcomes in survivors of childhood cancer: a systematic review. Chest. 2011;140(4):881-901.
    159. Mertens AC, Liu Q, Neglia JP, Wasilewski K, Leisenring W, Armstrong GT, et al. Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. Journal of the National Cancer Institute. 2008;100(19):1368-79.
    160. De A, Guryev I, LaRiviere A, Kato R, Wee CP, Mascarenhas L, et al. Pulmonary function abnormalities in childhood cancer survivors treated with bleomycin. Pediatric blood & cancer. 2014;61(9):1679-84.
    161. Nieder ML, McDonald GB, Kida A, Hingorani S, Armenian SH, Cooke KR, et al. National Cancer Institute-National Heart, Lung and Blood Institute/pediatric Blood and Marrow Transplant Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: long-term organ damage and dysfunction. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2011;17(11):1573-84.
    162. Venkatramani R, Kamath S, Wong K, Olch AJ, Malvar J, Sposto R, et al. Correlation of clinical and dosimetric factors with adverse pulmonary outcomes in children after lung irradiation. International journal of radiation oncology, biology, physics. 2013;86(5):942-8.
    163. Armstrong GT, Stovall M, Robison LL. Long-term effects of radiation exposure among adult survivors of childhood cancer: results from the childhood cancer survivor study. Radiation research. 2010;174(6):840-50.
    164. O'Driscoll BR, Hasleton PS, Taylor PM, Poulter LW, Gattameneni HR, Woodcock AA. Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood. The New England journal of medicine. 1990;323(6):378-82.
    165. Abid SH, Malhotra V, Perry MC. Radiation-induced and chemotherapy-induced pulmonary injury. Current opinion in oncology. 2001;13(4):242-8.
    166. Denbo JW, Zhu L, Srivastava D, Stokes DC, Srinivasan S, Hudson MM, et al. Long-term pulmonary function after metastasectomy for childhood osteosarcoma: a report from the St Jude lifetime cohort study. Journal of the American College of Surgeons. 2014;219(2):265-71.
    167. Hartmann-Boyce J, Stead LF, Cahill K, Lancaster T. Efficacy of interventions to combat tobacco addiction: Cochrane update of 2013 reviews. Addiction. 2014;109(9):1414-25.
    168. Ibrahim EM, Kazkaz GA, Abouelkhair KM, Al-Mansour MM, Al-Fayea TM, Al-Foheidi M, et al. Increased risk of second lung cancer in Hodgkin's lymphoma survivors: a meta-analysis. Lung. 2013;191(1):117-34.
    169. Bolling T, Willich N, Ernst I. Late effects of abdominal irradiation in children: a review of the literature. Anticancer research. 2010;30(1):227-31.
    170. Theis VS, Sripadam R, Ramani V, Lal S. Chronic radiation enteritis. Clinical oncology. 2010;22(1):70-83.
    171. Kavanagh BD, Pan CC, Dawson LA, Das SK, Li XA, Ten Haken RK, et al. Radiation dose-volume effects in the stomach and small bowel. International journal of radiation oncology, biology, physics. 2010;76(3 Suppl):S101-7.
    172. Aguayo P, Ho B, Fraser JD, Gamis A, St Peter SD, Snyder CL. Bowel obstruction after treatment of intra-abdominal tumors. European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery  [et al] = Zeitschrift fur Kinderchirurgie. 2010;20(4):234-6.
    173. Kountouras J, Zavos C. Recent advances in the management of radiation colitis. World journal of gastroenterology : WJG. 2008;14(48):7289-301.
    174. Prevention of radiation enteritis Review Article, Mert Saynak, Vuslat Yurut-Caloglu, Gulden Bayir-Angin, Murat Caloglu, Rusen Cosar-Alas, Seden Ozbilen-Kucucuk, Cem Uzal, Isik Aslay; Cancer Therapy Vol 4, 283-288, 2006.
    175. Schmiegelow M, Feldt-Rasmussen U, Rasmussen AK, Poulsen HS, Muller J. A population-based study of thyroid function after radiotherapy and chemotherapy for a childhood brain tumor. The Journal of clinical endocrinology and metabolism. 2003;88(1):136-40.
    176. Caglar AA, Oguz A, Pinarli FG, Karadeniz C, Okur A, Bideci A, et al. Thyroid abnormalities in survivors of childhood cancer. Journal of clinical research in pediatric endocrinology. 2014;6(3):144-51.
    177. De Vile CJ, Grant DB, Kendall BE, Neville BG, Stanhope R, Watkins KE, et al. Management of childhood craniopharyngioma: can the morbidity of radical surgery be predicted? Journal of neurosurgery. 1996;85(1):73-81.
    178. Muller HL. Consequences of craniopharyngioma surgery in children. The Journal of clinical endocrinology and metabolism. 2011;96(7):1981-91.
    179. Wilhelmsson M, Vatanen A, Borgstrom B, Gustafsson B, Taskinen M, Saarinen-Pihkala UM, et al. Adverse health events and late mortality after pediatric allogeneic hematopoietic SCT-two decades of longitudinal follow-up. Bone marrow transplantation. 2015;50(6):850-7.
    180. Bakker B, Oostdijk W, Geskus RB, Stokvis-Brantsma WH, Vossen JM, Wit JM. Growth hormone (GH) secretion and response to GH therapy after total body irradiation and haematopoietic stem cell transplantation during childhood. Clinical endocrinology. 2007;67(4):589-97.
    181. Darzy KH, Shalet SM. Hypopituitarism following Radiotherapy Revisited. Endocrine development. 2009;15:1-24.
    182. Bjork J, Link K, Erfurth EM. The utility of the growth hormone (GH) releasing hormone-arginine test for diagnosing GH deficiency in adults with childhood acute lymphoblastic leukemia treated with cranial irradiation. The Journal of clinical endocrinology and metabolism. 2005;90(11):6048-54.
    183. Link K, Moell C, Garwicz S, Cavallin-Stahl E, Bjork J, Thilen U, et al. Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood. The Journal of clinical endocrinology and metabolism. 2004;89(10):5003-12.
    184. Jarfelt M, Lannering B, Bosaeus I, Johannsson G, Bjarnason R. Body composition in young adult survivors of childhood acute lymphoblastic leukaemia. European journal of endocrinology / European Federation of Endocrine Societies. 2005;153(1):81-9.
    185. Samaan NA, Vieto R, Schultz PN, Maor M, Meoz RT, Sampiere VA, et al. Hypothalamic, pituitary and thyroid dysfunction after radiotherapy to the head and neck. International journal of radiation oncology, biology, physics. 1982;8(11):1857-67.
    186. Littley MD, Shalet SM, Beardwell CG, Ahmed SR, Applegate G, Sutton ML. Hypopituitarism following external radiotherapy for pituitary tumours in adults. The Quarterly journal of medicine. 1989;70(262):145-60.
    187. Livesey EA, Hindmarsh PC, Brook CG, Whitton AC, Bloom HJ, Tobias JS, et al. Endocrine disorders following treatment of childhood brain tumours. British journal of cancer. 1990;61(4):622-5.
    188. Darzy KH, Aimaretti G, Wieringa G, Gattamaneni HR, Ghigo E, Shalet SM. The usefulness of the combined growth hormone (GH)-releasing hormone and arginine stimulation test in the diagnosis of radiation-induced GH deficiency is dependent on the post-irradiation time interval. The Journal of clinical endocrinology and metabolism. 2003;88(1):95-102.
    189. Follin C, Link K, Wiebe T, Moell C, Bjork J, Erfurth EM. Prolactin insufficiency but normal thyroid hormone levels after cranial radiotherapy in long-term survivors of childhood leukaemia. Clinical endocrinology. 2013;79(1):71-8.
    190. Green DM, Kawashima T, Stovall M, Leisenring W, Sklar CA, Mertens AC, et al. Fertility of female survivors of childhood cancer: a report from the childhood cancer survivor study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009;27(16):2677-85.
    191. Lo Presti A, Ruvolo G, Gancitano RA, Cittadini E. Ovarian function following radiation and chemotherapy for cancer. European journal of obstetrics, gynecology, and reproductive biology. 2004;113 Suppl 1:S33-40.
    192. Barton SE, Najita JS, Ginsburg ES, Leisenring WM, Stovall M, Weathers RE, et al. Infertility, infertility treatment, and achievement of pregnancy in female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort. The Lancet Oncology. 2013;14(9):873-81.
    193. Morgan S, Anderson RA, Gourley C, Wallace WH, Spears N. How do chemotherapeutic agents damage the ovary? Human reproduction update. 2012;18(5):525-35.
    194. Rodriguez-Wallberg KA, Oktay K. Fertility preservation medicine: options for young adults and children with cancer. Journal of pediatric hematology/oncology. 2010;32(5):390-6.
    195. Steiner AZ. Clinical implications of ovarian reserve testing. Obstetrical & gynecological survey. 2009;64(2):120-8.
    196. Wallace WH, Smith AG, Kelsey TW, Edgar AE, Anderson RA. Fertility preservation for girls and young women with cancer: population-based validation of criteria for ovarian tissue cryopreservation. The Lancet Oncology. 2014;15(10):1129-36.
    197. Brougham MF, Crofton PM, Johnson EJ, Evans N, Anderson RA, Wallace WH. Anti-Mullerian hormone is a marker of gonadotoxicity in pre- and postpubertal girls treated for cancer: a prospective study. The Journal of clinical endocrinology and metabolism. 2012;97(6):2059-67.
    198. Galusca B, Jeandel L, Germain N, Alexandre D, Leprince J, Anouar Y, et al. Orexigenic neuropeptide 26RFa: new evidence for an adaptive profile of appetite regulation in anorexia nervosa. The Journal of clinical endocrinology and metabolism. 2012;97(6):2012-8.
    199. Hagen CP, Aksglaede L, Sorensen K, Main KM, Boas M, Cleemann L, et al. Serum levels of anti-Mullerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 Turner syndrome patients. The Journal of clinical endocrinology and metabolism. 2010;95(11):5003-10.
    200. Recommendations on Fertility preservation for girls and young women with childhood cancer; 4th meeting of the Nordic Network for Gonadal Preservation after Cancer Treatment in Children and Young Adults, Helsinki 2nd November, 2011.
    201. HTTP://VAVNAD.SE/FILES/LIVE/SITES/VAVNADSRADET/FILES/KÖNSCELLER/ASSISTERAD%20BEFRUKTNING/FRÄMJANDE_AV_REPRODUKTIONSFÖRMÅGA_UNGA_V1_00.PDF.
    202. Kallen B, Finnstrom O, Lindam A, Nilsson E, Nygren KG, Otterblad PO. Congenital malformations in infants born after in vitro fertilization in Sweden. Birth defects research Part A, Clinical and molecular teratology. 2010;88(3):137-43.
    203. Davies MJ, Moore VM, Willson KJ, Van Essen P, Priest K, Scott H, et al. Reproductive technologies and the risk of birth defects. The New England journal of medicine. 2012;366(19):1803-13.
    204. Lopez Andreu JA, Fernandez PJ, Ferris i Tortajada J, Navarro I, Rodriguez-Ineba A, Antonio P, et al. Persistent altered spermatogenesis in long-term childhood cancer survivors. Pediatric hematology and oncology. 2000;17(1):21-30.
    205. van Beek RD, Smit M, van den Heuvel-Eibrink MM, de Jong FH, Hakvoort-Cammel FG, van den Bos C, et al. Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkin's lymphoma with chemotherapy during childhood. Human reproduction. 2007;22(12):3215-22.
    206. Skinner et al.  Recommendations for Gonadotoxicity Surveillance for Male Childhood, Adolescent and Young Adult Cancer Survivors: A Report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in Collaboration with the PanCareSurFup Consortium.
    207. Stahl O, Boyd HA, Giwercman A, Lindholm M, Jensen A, Kjaer SK, et al. Risk of birth abnormalities in the offspring of men with a history of cancer: a cohort study using Danish and Swedish national registries. Journal of the National Cancer Institute. 2011;103(5):398-406.
    208. Spunt SL, Sweeney TA, Hudson MM, Billups CA, Krasin MJ, Hester AL. Late effects of pelvic rhabdomyosarcoma and its treatment in female survivors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005;23(28):7143-51.
    209. Flamant F, Gerbaulet A, Nihoul-Fekete C, Valteau-Couanet D, Chassagne D, Lemerle J. Long-term sequelae of conservative treatment by surgery, brachytherapy, and chemotherapy for vulval and vaginal rhabdomyosarcoma in children. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1990;8(11):1847-53.
    210. Piver MS, Rose PG. Long-term follow-up and complications of infants with vulvovaginal embryonal rhabdomyosarcoma treated with surgery, radiation therapy, and chemotherapy. Obstetrics and gynecology. 1988;71(3 Pt 2):435-7.
    211. Raney B, Jr., Heyn R, Hays DM, Tefft M, Newton WA, Jr., Wharam M, et al. Sequelae of treatment in 109 patients followed for 5 to 15 years after diagnosis of sarcoma of the bladder and prostate. A report from the Intergroup Rhabdomyosarcoma Study Committee. Cancer. 1993;71(7):2387-94.
    212. Brand AH, Bull CA, Cakir B. Vaginal stenosis in patients treated with radiotherapy for carcinoma of the cervix. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2006;16(1):288-93.
    213. Stinesen Kollberg K, Waldenstrom AC, Bergmark K, Dunberger G, Rossander A, Wilderang U, et al. Reduced vaginal elasticity, reduced lubrication, and deep and superficial dyspareunia in irradiated gynecological cancer survivors. Acta oncologica. 2015;54(5):772-9.
    214. Signorello LB, Mulvihill JJ, Green DM, Munro HM, Stovall M, Weathers RE, et al. Stillbirth and neonatal death in relation to radiation exposure before conception: a retrospective cohort study. Lancet. 2010;376(9741):624-30.
    215. Green DM, Peabody EM, Nan B, Peterson S, Kalapurakal JA, Breslow NE. Pregnancy outcome after treatment for Wilms tumor: a report from the National Wilms Tumor Study Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002;20(10):2506-13.
    216. Critchley HO, Wallace WH. Impact of cancer treatment on uterine function. Journal of the National Cancer Institute Monographs. 2005(34):64-8.
    217. Winther JF, Boice JD, Jr., Svendsen AL, Frederiksen K, Stovall M, Olsen JH. Spontaneous abortion in a Danish population-based cohort of childhood cancer survivors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008;26(26):4340-6.
    218. Wengenroth L, Rueegg CS, Michel G, Essig S, Ammann RA, Bergstraesser E, et al. Life partnerships in childhood cancer survivors, their siblings, and the general population. Pediatric blood & cancer. 2014;61(3):538-45.
    219. Koch SV, Kejs AM, Engholm G, Moller H, Johansen C, Schmiegelow K. Marriage and divorce among childhood cancer survivors. Journal of pediatric hematology/oncology. 2011;33(7):500-5.
    220. Ford JS, Kawashima T, Whitton J, Leisenring W, Laverdiere C, Stovall M, et al. Psychosexual functioning among adult female survivors of childhood cancer: a report from the childhood cancer survivor study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014;32(28):3126-36.
    221. Romerius P, Stahl O, Moell C, Relander T, Cavallin-Stahl E, Wiebe T, et al. Hypogonadism risk in men treated for childhood cancer. The Journal of clinical endocrinology and metabolism. 2009;94(11):4180-6.
    222. Puukko LR, Hirvonen E, Aalberg V, Hovi L, Rautonen J, Siimes MA. Sexuality of young women surviving leukaemia. Archives of disease in childhood. 1997;76(3):197-202.
    223. Sundberg KK, Lampic C, Arvidson J, Helstrom L, Wettergren L. Sexual function and experience among long-term survivors of childhood cancer. European journal of cancer. 2011;47(3):397-403.
    224. Nicholson HS, Blask AN, Markle BM, Reaman GH, Byrne J. Uterine anomalies in Wilms' tumor survivors. Cancer. 1996;78(4):887-91.
    225. Byrne J, Mulvihill JJ, Connelly RR, Austin DA, Holmes GE, Holmes FF, et al. Reproductive problems and birth defects in survivors of Wilms' tumor and their relatives. Medical and pediatric oncology. 1988;16(4):233-40.
    226. Byrne J, Nicholson HS. Excess risk for Mullerian duct anomalies in girls with Wilms tumor. Medical and pediatric oncology. 2002;38(4):258-9.
    227. Shanis D, Merideth M, Pulanic TK, Savani BN, Battiwalla M, Stratton P. Female long-term survivors after allogeneic hematopoietic stem cell transplantation: evaluation and management. Seminars in hematology. 2012;49(1):83-93.
    228. Smith Knutsson E, Bjork Y, Broman AK, Helstrom L, Levin Jakobsen AM, Nilsson O, et al. Genital chronic graft-versus-host disease in females: a cross-sectional study. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2014;20(6):806-11.
    229. Mueller SM, Haeusermann P, Rovo A, Halter JP, Passweg J, Itin P, et al. Genital chronic GVHD in men after hematopoietic stem cell transplantation: a single-center cross-sectional analysis of 155 patients. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2013;19(11):1574-80.
    230. Zebrack BJ, Foley S, Wittmann D, Leonard M. Sexual functioning in young adult survivors of childhood cancer. Psycho-oncology. 2010;19(8):814-22.
    231. van Dijk EM, van Dulmen-den Broeder E, Kaspers GJ, van Dam EW, Braam KI, Huisman J. Psychosexual functioning of childhood cancer survivors. Psycho-oncology. 2008;17(5):506-11.
    232. Bober SL, Zhou ES, Chen B, Manley PE, Kenney LB, Recklitis CJ. Sexual function in childhood cancer survivors: a report from Project REACH. The journal of sexual medicine. 2013;10(8):2084-93.
    233. WHO. (2002). Adolescent friendly services. An agenda for change.
    234. Armstrong GT, Chow EJ, Sklar CA. Alterations in pubertal timing following therapy for childhood malignancies. Endocrine development. 2009;15:25-39.
    235. de Vathaire F, El-Fayech C, Ben Ayed FF, Haddy N, Guibout C, Winter D, et al. Radiation dose to the pancreas and risk of diabetes mellitus in childhood cancer survivors: a retrospective cohort study. The Lancet Oncology. 2012;13(10):1002-10.
    236. Smith WA, Li C, Nottage KA, Mulrooney DA, Armstrong GT, Lanctot JQ, et al. Lifestyle and metabolic syndrome in adult survivors of childhood cancer: a report from the St. Jude Lifetime Cohort Study. Cancer. 2014;120(17):2742-50.
    237. Tonorezos ES, Robien K, Eshelman-Kent D, Moskowitz CS, Church TS, Ross R, et al. Contribution of diet and physical activity to metabolic parameters among survivors of childhood leukemia. Cancer causes & control : CCC. 2013;24(2):313-21.
    238. van Waas M, Neggers SJ, Uitterlinden AG, Blijdorp K, van der Geest IM, Pieters R, et al. Treatment factors rather than genetic variation determine metabolic syndrome in childhood cancer survivors. European journal of cancer. 2013;49(3):668-75.
    239. Ness KK, Hudson MM, Ginsberg JP, Nagarajan R, Kaste SC, Marina N, et al. Physical performance limitations in the Childhood Cancer Survivor Study cohort. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009;27(14):2382-9.
    240. Ortega FB, Ruiz JR, Vicente-Rodriguez G, Sjostrom M. Central adiposity in 9- and 15-year-old Swedish children from the European Youth Heart Study. International journal of pediatric obesity : IJPO : an official journal of the International Association for the Study of Obesity. 2008;3(4):212-6.
    241. Nagy P, Kovacs E, Moreno LA, Veidebaum T, Tornaritis M, Kourides Y, et al. Percentile reference values for anthropometric body composition indices in European children from the IDEFICS study. International journal of obesity. 2014;38 Suppl 2:S15-25.
    242. Meacham LR, Chow EJ, Ness KK, Kamdar KY, Chen Y, Yasui Y, et al. Cardiovascular risk factors in adult survivors of pediatric cancer--a report from the childhood cancer survivor study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2010;19(1):170-81.
    243. Neville KA, Cohn RJ, Steinbeck KS, Johnston K, Walker JL. Hyperinsulinemia, impaired glucose tolerance, and diabetes mellitus in survivors of childhood cancer: prevalence and risk factors. The Journal of clinical endocrinology and metabolism. 2006;91(11):4401-7.
    244. Oeffinger KC, Mertens AC, Sklar CA, Yasui Y, Fears T, Stovall M, et al. Obesity in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003;21(7):1359-65.
    245. Steinberger J, Sinaiko AR, Kelly AS, Leisenring WM, Steffen LM, Goodman P, et al. Cardiovascular risk and insulin resistance in childhood cancer survivors. The Journal of pediatrics. 2012;160(3):494-9.
    246. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365(9468):1415-28.
    247. Armstrong GT, Oeffinger KC, Chen Y, Kawashima T, Yasui Y, Leisenring W, et al. Modifiable risk factors and major cardiac events among adult survivors of childhood cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2013;31(29):3673-80.
    248. Gurney JG, Ness KK, Sibley SD, O'Leary M, Dengel DR, Lee JM, et al. Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia. Cancer. 2006;107(6):1303-12.
    249. Oudin C, Simeoni MC, Sirvent N, Contet A, Begu-Le Coroller A, Bordigoni P, et al. Prevalence and risk factors of the metabolic syndrome in adult survivors of childhood leukemia. Blood. 2011;117(17):4442-8.
    250. Zimmet P, Alberti KG, Kaufman F, Tajima N, Silink M, Arslanian S, et al. The metabolic syndrome in children and adolescents - an IDF consensus report. Pediatric diabetes. 2007;8(5):299-306.
    251. Furst CJ, Lundell M, Ahlback SO, Holm LE. Breast hypoplasia following irradiation of the female breast in infancy and early childhood. Acta oncologica. 1989;28(4):519-23.
    252. Inskip PD, Robison LL, Stovall M, Smith SA, Hammond S, Mertens AC, et al. Radiation dose and breast cancer risk in the childhood cancer survivor study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009;27(24):3901-7.
    253. Henderson TO, Amsterdam A, Bhatia S, Hudson MM, Meadows AT, Neglia JP, et al. Systematic review: surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer. Annals of internal medicine. 2010;152(7):444-55; W144-54.
    254. Hansson E, Freccero C. [Female breast deviations]. Lakartidningen. 2012;109(6):282-6.
    255. Greydanus DE, Parks DS, Farrell EG. Breast disorders in children and adolescents. Pediatric clinics of North America. 1989;36(3):601-38.
    256. Arca MJ, Caniano DA. Breast disorders in the adolescent patient. Adolescent medicine clinics. 2004;15(3):473-85.
    257. Schellong G, Riepenhausen M, Ehlert K, Bramswig J, Dorffel W, German Working Group on the Long-Term Sequelae of Hodgkin's D, et al. Breast cancer in young women after treatment for Hodgkin's disease during childhood or adolescence--an observational study with up to 33-year follow-up. Deutsches Arzteblatt international. 2014;111(1-2):3-9.
    258. Chen S, Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007;25(11):1329-33.
    259. Yasui Y, Liu Y, Neglia JP, Friedman DL, Bhatia S, Meadows AT, et al. A methodological issue in the analysis of second-primary cancer incidence in long-term survivors of childhood cancers. American journal of epidemiology. 2003;158(11):1108-13.
    260. Elkin EB, Klem ML, Gonzales AM, Ishill NM, Hodgson D, Ng AK, et al. Characteristics and outcomes of breast cancer in women with and without a history of radiation for Hodgkin's lymphoma: a multi-institutional, matched cohort study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011;29(18):2466-73.
    261. Sanna G, Lorizzo K, Rotmensz N, Bagnardi V, Cinieri S, Colleoni M, et al. Breast cancer in Hodgkin's disease and non-Hodgkin's lymphoma survivors. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2007;18(2):288-92.
    262. Carney PA, Miglioretti DL, Yankaskas BC, Kerlikowske K, Rosenberg R, Rutter CM, et al. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Annals of internal medicine. 2003;138(3):168-75.
    263. Zervoudis S, Iatrakis G, Tomara E, Bothou A, Papadopoulos G, Tsakiris G. Main controversies in breast cancer. World journal of clinical oncology. 2014;5(3):359-73.
    264. Sardanelli F, Boetes C, Borisch B, Decker T, Federico M, Gilbert FJ, et al. Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. European journal of cancer. 2010;46(8):1296-316
    265. http://www.acr.org/~/media/2a0eb28eb59041e2825179afb72ef624.pdf.
    266. Mann RM, Kuhl CK, Kinkel K, Boetes C. Breast MRI: guidelines from the European Society of Breast Imaging. European radiology. 2008;18(7):1307-18.
    267. Kuhl CK, Schrading S, Leutner CC, Morakkabati-Spitz N, Wardelmann E, Fimmers R, et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005;23(33):8469-76.
    268. Morris EA, Liberman L, Ballon DJ, Robson M, Abramson AF, Heerdt A, et al. MRI of occult breast carcinoma in a high-risk population. AJR American journal of roentgenology. 2003;181(3):619-26.
    269. Saslow D, Boetes C, Burke W, Harms S, Leach MO, Lehman CD, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA: a cancer journal for clinicians. 2007;57(2):75-89.
    270. Dorr W, Kallfels S, Herrmann T. Late bone and soft tissue sequelae of childhood radiotherapy. Relevance of treatment age and radiation dose in 146 children treated between 1970 and 1997. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft  [et al]. 2013;189(7):529-34.
    271. Pacheco R, Stock H. Effects of radiation on bone. Current osteoporosis reports. 2013;11(4):299-304.
    272. Strenger V, Lackner H, Mayer R, Sminia P, Sovinz P, Mokry M, et al. Incidence and clinical course of radionecrosis in children with brain tumors. A 20-year longitudinal observational study. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft  [et al]. 2013;189(9):759-64.
    273. Raney RB, Asmar L, Vassilopoulou-Sellin R, Klein MJ, Donaldson SS, Green J, et al. Late complications of therapy in 213 children with localized, nonorbital soft-tissue sarcoma of the head and neck: A descriptive report from the Intergroup Rhabdomyosarcoma Studies (IRS)-II and - III. IRS Group of the Children's Cancer Group and the Pediatric Oncology Group. Medical and pediatric oncology. 1999;33(4):362-71.
    274. Siebler T, Shalet SM, Robson H. Effects of chemotherapy on bone metabolism and skeletal growth. Hormone research. 2002;58 Suppl 1:80-5.
    275. Mandel K, Atkinson S, Barr RD, Pencharz P. Skeletal morbidity in childhood acute lymphoblastic leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2004;22(7):1215-21.
    276. Fan C, Foster BK, Wallace WH, Xian CJ. Pathobiology and prevention of cancer chemotherapy-induced bone growth arrest, bone loss, and osteonecrosis. Current molecular medicine. 2011;11(2):140-51.
    277. van der Sluis IM, van den Heuvel-Eibrink MM. Osteoporosis in children with cancer. Pediatric blood & cancer. 2008;50(2 Suppl):474-8; discussion 86.
    278. Vora et al. Incidence and outcome of osteonecrosis in children and young adults with acute lymphoblastic leukaemia treated on a dexamethasone containing protocol: Results of the Medical Research Council UK trial ALL 2003. Blood 2008 112:abstr 910.
    279. Mattano LA, Jr., Sather HN, Trigg ME, Nachman JB. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2000;18(18):3262-72.
    280. Te Winkel ML, Pieters R, Wind EJ, Bessems JH, van den Heuvel-Eibrink MM. Management and treatment of osteonecrosis in children and adolescents with acute lymphoblastic leukemia. Haematologica. 2014;99(3):430-6.
    281. Le Meignen M, Auquier P, Barlogis V, Sirvent N, Contet A, Simeoni MC, et al. Bone mineral density in adult survivors of childhood acute leukemia: impact of hematopoietic stem cell transplantation and other treatment modalities. Blood. 2011;118(6):1481-9.
    282. Inamoto Y, Pidala J, Chai X, Kurland BF, Weisdorf D, Flowers ME, et al. Assessment of joint and fascia manifestations in chronic graft-versus-host disease. Arthritis & rheumatology. 2014;66(4):1044-52.
    283. Vassilopoulou-Sellin R, Brosnan P, Delpassand A, Zietz H, Klein MJ, Jaffe N. Osteopenia in young adult survivors of childhood cancer. Medical and pediatric oncology. 1999;32(4):272-8.
    284. Paulino AC. Late effects of radiotherapy for pediatric extremity sarcomas. International journal of radiation oncology, biology, physics. 2004;60(1):265-74.
    285. Allam KA, Lim AA, Elsherbiny A, Bradley JP, Kawamoto HK. Radiation-induced craniofacial deformities: a new classification and management algorithm. Journal of plastic, reconstructive & aesthetic surgery : JPRAS. 2013;66(8):1088-95.
    286. Green A, Whiteman D, Frost C, Battistutta D. Sun exposure, skin cancers and related skin conditions. Journal of epidemiology / Japan Epidemiological Association. 1999;9(6 Suppl):S7-13.
    287. Armstrong GT, Liu W, Leisenring W, Yasui Y, Hammond S, Bhatia S, et al. Occurrence of multiple subsequent neoplasms in long-term survivors of childhood cancer: a report from the childhood cancer survivor study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011;29(22):3056-64.
    288. Watt TC, Inskip PD, Stratton K, Smith SA, Kry SF, Sigurdson AJ, et al. Radiation-related risk of basal cell carcinoma: a report from the Childhood Cancer Survivor Study. Journal of the National Cancer Institute. 2012;104(16):1240-50.
    289. Kinahan KE, Sharp LK, Seidel K, Leisenring W, Didwania A, Lacouture ME, et al. Scarring, disfigurement, and quality of life in long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2012;30(20):2466-74.
    290. Lawenda BD, Gagne HM, Gierga DP, Niemierko A, Wong WM, Tarbell NJ, et al. Permanent alopecia after cranial irradiation: dose-response relationship. International journal of radiation oncology, biology, physics. 2004;60(3):879-87.
    291. Changal KH, Raina H, Changal QH, Raina M. Bleomycin-induced Flagellate Erythema: A Rare and Unique Drug Rash. The West Indian medical journal. 2014;63(7).
    292. Zattra E, Fortina AB, Bordignon M, Piaserico S, Alaibac M. Immunosuppression and melanocyte proliferation. Melanoma research. 2009;19(2):63-8.
    293. Leisenring W, Friedman DL, Flowers ME, Schwartz JL, Deeg HJ. Nonmelanoma skin and mucosal cancers after hematopoietic cell transplantation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006;24(7):1119-26.
    294. Skert C, Patriarca F, Sperotto A, Cerno M, Fili C, Zaja F, et al. Sclerodermatous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: incidence, predictors and outcome. Haematologica. 2006;91(2):258-61.
    295. Flowers ME, Martin PJ. How we treat chronic graft-versus-host disease. Blood. 2015;125(4):606-15.
    296. Curtis RE, Metayer C, Rizzo JD, Socie G, Sobocinski KA, Flowers ME, et al. Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study. Blood. 2005;105(10):3802-11.
    297. Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers: Children’s Oncology Group; 2013. 
    298. Hudkontroll efter transplantation. 2013.
    299. Inamoto Y, Shah NN, Savani BN, Shaw BE, Abraham AA, Ahmed IA, et al. Secondary solid cancer screening following hematopoietic cell transplantation. Bone marrow transplantation. 2015.
    300. Krynitz B, Edgren G, Lindelof B, Baecklund E, Brattstrom C, Wilczek H, et al. Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008--a Swedish population-based study. International journal of cancer Journal international du cancer. 2013;132(6):1429-38.
    301. Friedman DL, Whitton J, Leisenring W, Mertens AC, Hammond S, Stovall M, et al. Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. Journal of the National Cancer Institute. 2010;102(14):1083-95.
    302. http://www.cancercentrum.se/globalassets/cancerdiagnoser/hud/vardprogram/natvp_malignt_melanom_rev.2015-01-19lang.pdf.
    303. http://www.stralsakerhetsmyndigheten.se/Publikationer/Rapport/Stralskydd/2014/201449/.
    304. Pappo AS, Armstrong GT, Liu W, Srivastava DK, McDonald A, Leisenring WM, et al. Melanoma as a subsequent neoplasm in adult survivors of childhood cancer: a report from the childhood cancer survivor study. Pediatric blood & cancer. 2013;60(3):461-6.
    305. Braam KI, Overbeek A, Kaspers GJ, Ronckers CM, Schouten-van Meeteren AY, Van Dulmen-Den Broeder E, et al. Malignant melanoma as second malignant neoplasm in long-term childhood cancer survivors: a systematic review. Pediatric blood & cancer. 2012;58(5):665-74.
    306. Brodin NP, Munck Af Rosenschold P, Aznar MC, Kiil-Berthelsen A, Vogelius IR, Nilsson P, et al. Radiobiological risk estimates of adverse events and secondary cancer for proton and photon radiation therapy of pediatric medulloblastoma. Acta oncologica. 2011;50(6):806-16.
    307. Taj MM, Hadzic N, Height SE, Wotherspoon A, Burke M, Hobson R, et al. Long-term outcome for immune suppression and immune related lymphoproliferative disorder: prospective data from the United Kingdom Children's Leukaemia and Cancer Group registry 1994-2004. Leukemia & lymphoma. 2012;53(5):842-8.
    308. Malkin D, Nichols KE, Zelley K, Schiffman JD. Predisposition to pediatric and hematologic cancers: a moving target. Am Soc Clin Oncol Educ Book. 2014:e44-55.
    309. Kovalchik SA, Ronckers CM, Veiga LH, Sigurdson AJ, Inskip PD, de Vathaire F, et al. Absolute risk prediction of second primary thyroid cancer among 5-year survivors of childhood cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2013;31(1):119-27.
    310. Veiga LH, Bhatti P, Ronckers CM, Sigurdson AJ, Stovall M, Smith SA, et al. Chemotherapy and thyroid cancer risk: a report from the childhood cancer survivor study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2012;21(1):92-101.
    311. Taylor AJ, Little MP, Winter DL, Sugden E, Ellison DW, Stiller CA, et al. Population-based risks of CNS tumors in survivors of childhood cancer: the British Childhood Cancer Survivor Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2010;28(36):5287-93.
    312. Olsen JH, Moller T, Anderson H, Langmark F, Sankila R, Tryggvadottir L, et al. Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries. Journal of the National Cancer Institute. 2009;101(11):806-13.
    313. Cardous-Ubbink MC, Heinen RC, Bakker PJ, van den Berg H, Oldenburger F, Caron HN, et al. Risk of second malignancies in long-term survivors of childhood cancer. European journal of cancer. 2007;43(2):351-62.
    314. Neglia JP, Friedman DL, Yasui Y, Mertens AC, Hammond S, Stovall M, et al. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. Journal of the National Cancer Institute. 2001;93(8):618-29.
    315. Reulen RC, Frobisher C, Winter DL, Kelly J, Lancashire ER, Stiller CA, et al. Long-term risks of subsequent primary neoplasms among survivors of childhood cancer. Jama. 2011;305(22):2311-9.